Chas Harris is a founding healthcare executive with more than 15 years of experience building regulated medical platforms into market leaders that fundamentally improve patient care. Throughout his career, he has partnered to scale early-stage healthcare ventures from pre-revenue stealth mode through years of rapid commercial growth, leading corporate development, strategic partnerships, and reimbursement strategies to expand national patient access to innovative therapies. Previously, he led global product launches and established international distribution networks for complex medical device portfolios.

At TendoNova, Chas drives the strategic vision, capitalization, and operational scaling required to ensure patients everywhere have access to minimally invasive treatment options designed to support their return to an active lifestyle and restore quality of life. He holds an MBA from Duke University’s Fuqua School of Business.